One of the key processes in the pharmaceutical world is the development of new medicines or vaccines. The current situation of the widespread COVID-19 pandemic makes it especially clear how important, but also how complicated it is, to launch a new product. Although new medicines go through many trial processes, checks and even business plan calculations, they still can fail when brought to the market. This is a strange thing, because the success, and even the survival of a pharmaceutical company, depends greatly on the successful execution of a product launch. Because of this reason, Joeri De Haes elaborates on the common pitfalls in pharmaceutical product launches and provides some tips and tricks on how to avoid them.

Joeri De Haes uses his interest in Outer Space to give some examples of past space projects which partly failed because of some missteps in the process of the launch of new satellites and robots. With these examples, he makes the connection to the pharmaceutical world and what the industry can learn from past mistakes.


 

Check your own launch readiness when launching in pharma & Medtech with our ‘tick-the-box’ self-assessment tool.

Fill out the contact form and we will get in touch with you to provide all materials.

Presented at EYEFORPHARMA JAPAN 2020 and exclusively available for pharma & medtech stakeholders.

 

Interested to learn how Trilations can assist you in your launch project? Feel free to reach out to:

“There Are A Thousand Things That Can Happen When You Go To Launch A Rocket, And Only One Of Them Is Good.”
Tom Mueller SpaceX propulsion chief
“Trilations is possibly one of the best companies to combine Marketing Research and Consulting, with a well balanced Bottom-Up and Top-Down approach. where we can make business impact with fact-based decisions.”
Korkut Bilgin General Manager Japan & Asia Pacific
Our dedicated team of market strategy experts combines in-depth industry knowledge, advanced analytic & team mobilization skills to deliver high added value in all your analytical and strategic projects.
Joeri De Haes Director Japan & Asia Pacific

Related Article

Private: Pharma-Customer-Centricity-Index

Read more